RYZB News

Get ready for a bevy of biotech IPOs. The 30 IPOs that raised $100 million or more in 2023 currently average a strong 25% return from offer, thanks to solid first day gains (+14%) that have built in the aftermarket (+9%). Biotechs make up half of the top 10 best-performing sizable IPOs from last year. While a few biotechs are also among 2023’s...read more

After a strong rally through July, markets have treaded water for the past three months as investors grow pessimistic about the possibility of near-term rate cuts, against a backdrop of political gridlock in the US and a new war abroad. The year's sizable IPOs have slowly declined in the past few months' volatility, and the percentage trading above issue has fallen to its lowest...read more

Large Tech IPOs Stage a Comeback in a Volatile 3Q The third quarter of 2023 produced 30 IPOs that raised a combined $7.8 billion, more than the proceeds raised in the full-year 2022 despite no significant increase in deal count from previous quarters. Chip giant Arm led activity, raising $4.9 billion in the largest...read more

Five IPOs raised a combined $5.4 billion this past week, led by the blockbuster IPO of Arm (ARM). Three issuers submitted initial filings. The largest IPO of 2023 so far, Arm priced at the top of the range to raise $4.9 billion at a $52.9 billion market cap. Arm is an industry leader in central processing units (CPUs), stating that its...read more